Stockreport

NantHealth and NantOmics Present Four Research Papers Demonstrating Advancements in Cancer Diagnostics with NantHealth’s GPS Cancer® and Liquid GPS™

NantHealth, Inc.  (NH) 
Last nanthealth, inc. earnings: 11/7 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: nanthealth.com
PDF NantHealth’s Liquid GPS™ technology shows promise in the monitoring of key biomarkers in metastatic colorectal cancer MUNICH & CULVER CITY, [Read more]